The in vivo function of TIGAR, a p53 target gene that regulates glucose metabolism
© Cheung et al; licensee BioMed Central Ltd. 2014
Published: 28 May 2014
The p53 tumour suppressor inhibits tumour development via various mechanisms such as apoptosis, inhibition of proliferation or the activation of senescence. Recently, several studies have indicated a novel role of p53 in the regulation of energy metabolism. Previously we have discovered TIGAR, a p53 target gene that acts as a fructose-2,6-bisphosphatase. TIGAR would therefore be predicted to redirect glucose from the glycolytic pathway to secondary pathways such as the pentose phosphate pathway (PPP). Indeed, TIGAR can promote NADPH production to generate reduced glutathione for protection against ROS. In order to understand the function of TIGAR in vivo, we generated TIGAR deficient mice. We have determined a critical role of TIGAR in rapidly proliferating tissue, either for repair after damage or during tumor development. These studies support a role for TIGAR in maintaining both antioxidant activity and nucleotide synthesis, both generated through the PPP. We are now also investigating the role of TIGAR in other metabolic pathways such as the hexosamine biosynthesis pathway, and in other animal models of cancer.
Funded by CR-UK, ERC and MRC.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.